4119 — SCI Pharmtech Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSucker Stock

Annual income statement for SCI Pharmtech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	864	900	1,204	1,524	1,344
Cost of Revenue
Gross Profit	208	291	350	411	351
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	791	781	1,044	1,325	1,188
Operating Profit	73.7	119	160	198	155
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	65.5	388	364	647	102
Provision for Income Taxes
Net Income After Taxes	55.7	309	295	535	107
Net Income Before Extraordinary Items
Net Income	55.7	309	295	535	107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	55.7	309	295	535	107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.508	2.82	2.69	4.46	0.896
Dividends per Share